Table 2.
Skin Thickness, Surface Area, and EI Parameters at Baseline and after 4, 8, and 12 Weeks
| Group | Control Group (n = 13) | CGF Group (n = 13) | P (CON vs. CGF) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean/Median | SEM/IQR | P (Visit vs. V1) | Mean/Median | SEM/IQR | P (Visit vs. V1) | |||||
| Skin thickness, mm | ||||||||||
| V1 | 1.6 | 0.1 | — | — | 1.5 | 0.1 | — | — | 0.987 | ns |
| V2 | 1.4 | 0.1 | <0.001 | b | 1.6 | 0.1 | 0.711 | ns | 0.569 | ns |
| V3 | 1.1 | 0.1 | <0.001 | b | 1.4 | 0.1 | 0.167 | Ns | 0.047 | a |
| V4 | 1.0 | 0.1 | <0.001 | b | 1.3 | 0.1 | 0.023 | a | 0.047 | a |
| Epidermal thickness, mm | ||||||||||
| V1 | 0.3 | 0.0 | — | — | 0.3 | 0.0 | — | — | >0.999 | ns |
| V2 | 0.3 | 0.0 | 0.716 | ns | 0.3 | 0.0 | 0.069 | ns | 0.792 | ns |
| V3 | 0.2 | 0.0 | 0.129 | ns | 0.3 | 0.0 | 0.035 | a | 0.935 | ns |
| V4 | 0.2 | 0.0 | 0.016 | a | 0.2 | 0.0 | 0.047 | a | 0.287 | ns |
| Dermal thickness, mm | ||||||||||
| V1 | 1.3 | 0.1 | — | — | 1.3 | 0.1 | — | — | 0.984 | ns |
| V2 | 1.1 | 0.1 | <0.001 | b | 1.3 | 0.1 | 0.497 | ns | 0.400 | ns |
| V3 | 0.9 | 0.1 | <0.001 | b | 1.2 | 0.1 | 0.294 | ns | 0.045 | a |
| V4 | 0.8 | 0.1 | <0.001 | b | 1.1 | 0.1 | 0.079 | ns | 0.041 | a |
| Surface area | ||||||||||
| V1 | 198.0 | 59.5–578.6 | — | — | 149.5 | 48.6–268.7 | — | — | 0.281 | ns |
| V4 | 280.3 | 111.4–670.5 | 0.001 | b | 258.0 | 187.7–465.7 | <0.001 | b | 0.614 | ns |
| Increment of surface area | ||||||||||
| V4–V1 | 77.7 | 18.5 | — | — | 135.0 | 15.7 | — | — | 0.027 | a |
| EI | ||||||||||
| V1 | 1.5 | 0.2 | — | — | 1.2 | 0.1 | — | — | 0.107 | ns |
| V4 | 2.4 | 0.1 | <0.001 | b | 2.6 | 0.1 | <0.001 | b | 0.449 | ns |
| Increment of EI | ||||||||||
| V4–V1 | 0.9 | 0.1 | — | — | 1.4 | 0.2 | — | — | 0.030 | a |
IQR, interquartile range; V1, visit 1 (baseline); V2, visit 2 (4 weeks); ns, not significant (P > 0.05); V3, visit 3 (8 weeks); V4, visit 4 (12 weeks).
P < 0.05.
P < 0.01.